Body Is the New Status
naveen.com@naveen
+4.4%
since Oct 9
The idea
I believe status has shifted from nights out to how people look, as weight-loss drugs and training become the new flex and that change sticks for years, not a season. The basket leans on body-changing drugs as its anchor, then spreads across workout gear and wearables, telehealth and aesthetics, protein and fuel, and gyms, so no single company or layer can sink the idea. It holds some cash on the side and avoids betting big on any one name, since this is meant to be held for years as the trend plays out. I'd rethink it if people started spending on going out again instead of on their bodies.
What it owns
- These companies make the GLP-1 weight-loss drugs reshaping bodies across the country. · Eli Lilly and CompanyIt makes Zepbound and Mounjaro, the drugs most responsible for visible body changes people see around them., Amgen Inc.It is developing MariTide, a next-generation obesity injection designed to require less frequent dosing than current options., Novo Nordisk A/SIt makes Wegovy and Ozempic, the other major source of GLP-1 drugs reshaping the market for weight loss., Viking Therapeutics, Inc.It is testing obesity drugs and weight-maintenance pills in clinical trials, representing the next generation of body-changing treatments.22%
- People wear these brands to train and track the body, turning athletic gear into everyday status. · On Holding AGIt makes running shoes worn both on the track and as everyday wear, signaling serious training to others., Amer Sports, Inc.It owns Arc'teryx and Salomon, performance brands people wear to train and to appear athletic in daily life., Garmin Ltd.Its watches track training, sleep and recovery data for people committed to serious fitness and body changes., Deckers Outdoor CorporationIt owns Hoka, the running shoe that became ubiquitous at gyms and on streets as a symbol of active training.22%
- These companies prescribe weight-loss drugs online and provide skin and cosmetic treatments as bodies change. · AbbVie Inc.It owns Botox and Juvederm, the leading brands in facial injectables that people maintain alongside their bodies., Hims & Hers Health, Inc.It sells weight-loss and wellness drugs online by subscription, serving the growing peptide market most investors cannot access directly., Establishment Labs Holdings Inc.It makes Motiva breast implants and body contouring products for people completing surgical reshaping of their bodies., Evolus, Inc.It sells Jeuveau, a lower-cost Botox alternative aimed at younger patients treating injectables as routine maintenance.17%
- Building and maintaining muscle on GLP-1 drugs drives demand for protein products and fitness supplements. · BellRing Brands, Inc.It makes Premier Protein shakes, a daily consumption habit for gym regulars and those on GLP-1 drugs preserving muscle., Celsius Holdings, Inc.It sells energy drinks marketed as gym fuel, the beverage people carry into workouts as part of their fitness identity., The Simply Good Foods CompanyIt owns Quest, the protein bars and chips people choose over junk food when building and maintaining muscle., Vital Farms, Inc.It sells premium pasture-raised eggs, the protein people choose at higher prices for home cooking over dining out.16%
- Premium and affordable gym memberships anchor where people go to build and display the new status symbol. · Life Time Group Holdings, Inc.It operates premium fitness clubs designed like country clubs, where high-income members pay substantial monthly dues., Planet Fitness, Inc.It runs affordable gyms for mainstream consumers, testing whether the fitness habit spreads beyond wealthy markets.15%
- Cash8%